
Tuesday, November 09, 2021 8:31:52 AM
My interpretation is that the new CEO, Linda Tharby, is comfortable enough with the story, and has a vision for the future, that she feels the time is right for the management team to start talking with investors.
We will find out what the numbers say on Wednesday.
Volume: | 158,395 |
Day Range: | 2.20 - 2.4673 |
Bid: | 2.22 |
Ask: | 2.62 |
Last Trade Time: | 5:00:51 PM EDT |
Total Trades: | 1,992 |
Recent KRMD News
- KORU Medical Systems to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025 • Business Wire • 02/19/2025 09:05:00 PM
- KORU Medical Systems Announces Agreement for Next-Generation Subcutaneous Immunoglobulin Infusion System • Business Wire • 02/06/2025 09:05:00 PM
- KORU Medical Systems Announces Phase III Clinical Trial Collaboration for a New Drug Indication in Nephrology • Business Wire • 01/30/2025 09:05:00 PM
- KORU Medical Systems Reports Preliminary Fourth Quarter and Full Year 2024 Results; Achieves Record Full Year and Quarterly Revenues; Positive Cash Flow for the Fourth Quarter • Business Wire • 01/14/2025 09:06:00 PM
- KORU Medical Systems Reports Preliminary Fourth Quarter and Full Year 2024 Results; Achieves Record Full Year and Quarterly Revenues; Positive Cash Flow for the Fourth Quarter • Business Wire • 01/13/2025 01:00:00 PM
- KORU Medical Systems to Participate in Piper Sandler’s 36th Annual Healthcare Conference • Business Wire • 11/25/2024 09:05:00 PM
- KORU Medical Systems, Inc. Announces 2024 Q3 Financial Results, Third Consecutive Quarter of Double-Digit Growth; Raises Full Year 2024 Guidance • Business Wire • 11/13/2024 09:05:00 PM
- KORU Medical Systems to Participate in Upcoming Investor Conferences • Business Wire • 11/06/2024 09:05:00 PM
- KORU Medical Systems Presents Data at Partnership Opportunities in Drug Delivery (PODD) Conference Demonstrating Nursing Preference for Use of KORU FreedomEdge® Infusion System over Manual Syringe Administration for Subcutaneous Oncology Infusion • Business Wire • 10/31/2024 08:03:00 PM
- KORU Medical Systems to Report Third Quarter 2024 Financial Results on November 13, 2024 • Business Wire • 10/23/2024 08:05:00 PM
- KORU Medical Systems to Participate in the 8th Annual Lake Street Best Ideas Growth Conference • Business Wire • 09/05/2024 11:00:00 AM
- KORU Medical Systems, Inc. Announces 2024 Q2 Financial Results, a Record Quarter With 22% Revenue Growth; Raises Full Year 2024 Guidance • Business Wire • 08/07/2024 08:05:00 PM
- KORU Medical Systems to Participate in the Canaccord Genuity 44th Annual Growth Conference • Business Wire • 07/25/2024 08:05:00 PM
- KORU Medical Systems, Inc Announces Leadership Changes to Support Growth Agenda • Business Wire • 07/24/2024 08:05:00 PM
- KORU Medical Systems to Report Second Quarter 2024 Financial Results on August 7, 2024 • Business Wire • 07/17/2024 08:05:00 PM
- KORU Medical Systems Receives Regulatory Clearance for FreedomEdge® Infusion System in Japan • Business Wire • 07/02/2024 11:00:00 AM
- Simplifying Subcutaneous Drug Administration: SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion • Business Wire • 06/05/2024 01:00:00 PM
- KORU Medical Systems Announces a New Feasibility Study with a Commercialized Oncology Biologic • Business Wire • 06/04/2024 08:03:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 09:19:50 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 05/23/2024 11:00:28 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 09:06:19 PM
- KORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological Biologic • Business Wire • 05/14/2024 08:05:00 PM
- KORU Medical Systems, Inc. Announces 2024 First Quarter Financial Results Delivering Double-Digit Revenue Growth • Business Wire • 05/01/2024 08:05:00 PM
- KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024 • Business Wire • 04/17/2024 11:00:00 AM
- KORU Medical Systems Announces Successful Appeal in EU Notified Body Review • Business Wire • 04/11/2024 08:05:00 PM
Wytec Prepares for 1st AI Gunshot Detection Pilot • WYTC • Apr 4, 2025 7:09 AM
ConnectM Receives $1.60 Per Share Buyout Offer from its Three Largest Institutional Investors • CNTM • Apr 2, 2025 9:00 AM
Nightfood Holdings Completes Acquisition of Carryout Supplies, Deepening Vertical Integration in AI-Powered Hospitality Automation • NGTF • Apr 2, 2025 8:30 AM
Avant Technologies Partner, Ainnova, to Sponsor and Present at 2025 Healthcare Innovation Summit in Mexico City • AVAI • Apr 2, 2025 8:00 AM
Glidelogic Corp. Unveils ResearchMind - Pioneering AI-Driven Research Innovation for a Global Academic Community • GDLG • Apr 1, 2025 2:10 PM
Fifty 1 Labs, Inc. Celebrates Groundbreaking SpaceX, NASA, and ISS Yeast Experiment by Subsidiary Genetic Networks • FITY • Apr 1, 2025 9:30 AM